Frontotemporal dementia caused by CHMP2B mutations.

Area of Science:

• Neurogenetics
• Cellular Biology
• Neurodegenerative Diseases

Background:

• CHMP2B mutations represent a rare genetic cause of autosomal dominant frontotemporal dementia (FTD).
• The most studied form is frontotemporal dementia linked to chromosome 3 (FTD-3), prevalent in a large Danish family.
• Additional CHMP2B mutations have been identified in familial FTD cases, including an unrelated Belgian patient.

Purpose of the Study:

• To review recent advances in understanding the molecular mechanisms of CHMP2B truncation mutations.
• To examine the impact of these mutations on vesicular fusion, endosome-lysosome pathways, and autophagy.
• To consolidate current knowledge on the clinical, neuroimaging, and neuropathological features of CHMP2B-related FTD.

Main Methods:

• Literature review of studies on CHMP2B mutations in FTD.
• Analysis of molecular effects of C-terminal CHMP2B truncations on cellular pathways.
• Compilation of clinical data, brain imaging, and neuropathological findings.

Main Results:

• CHMP2B mutations result in C-terminal protein truncations.
• These truncations affect vesicular fusion, endosome-lysosome function, and autophagy.
• Clinical features, imaging, and neuropathology of CHMP2B-related FTD are reviewed.

Conclusions:

• CHMP2B mutations are implicated in specific forms of familial frontotemporal dementia.
• Understanding the molecular pathology is crucial for FTD research.
• Further investigation into CHMP2B missense mutations in FTD and motor neuron disease is warranted.